Gilead

Pharma firm Gilead has been called on to allow for generic versions of its new HIV drug. Photo: JUSTIN SULLIVAN / GETTY IMAGES NORTH AMERICA/AFP/File
Health

Pharma firm urged to share new 'game-changer' HIV drug

The drug Lenacapavir could be a "real game-changer" in the fight against HIV, according to an open letter to Gilead CEO Daniel O'Day signed by a range of former world leaders, AIDS...

antiviral drug Remdesivir. Photo : BSS/AFP
Coronavirus chronicle

Gilead's remdesivir reduces Covid-19 mortality risk

Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (Covid-19), during the outbreak of the coronavirus disease (Covid-19), in Oceanside, California, US, April 29, 2020.
World+Biz

Gilead to buy cancer drugmaker Immunomedics for $21 billion

FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (Covid-19), during the outbreak of the coronavirus disease (Covid-19), in Oceanside, California, US, April 29, 2020. REUTERS/Mike Blake/File Photo
Coronavirus chronicle

Gilead files US marketing application for remdesivir

A logo for Pfizer is displayed on a monitor on the floor at the New York Stock Exchange (NYSE) in New York, US, July 29, 2019/ Reuters
Coronavirus chronicle

Pfizer signs deal to supply Gilead's remdesivir for Covid-19

An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues/ Reuters
Coronavirus chronicle

UK's Hikma starts manufacturing Covid-19 drug remdesivir for Gilead

European Union flags fly outside the EU Commission headquarters in Brussels, Belgium September 19, 2019/ Reuters
Coronavirus chronicle

EU buys limited supply of Covid drug remdesivir, seeks more

An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues/ Reuters
Coronavirus chronicle

Canada gives conditional approval to Gilead's remdesivir for Covid-19

In this photo provided by Gilead Sciences, a vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States.AP Photo
Coronavirus chronicle

Gilead says additional data on remdesivir shows improved clinical recovery

An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues/ Reuters
Coronavirus chronicle

Gilead prices Covid-19 drug candidate remdesivir at $2,340 per patient

An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues/ Reuters
Coronavirus chronicle

Gilead to test inhaled version of remdesivir on Covid-19 patients in August

Photo: Collected
Coronavirus chronicle

Gilead's remdesivir shows promise in Covid-19 study on monkeys

FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (Covid-19), during the outbreak of the coronavirus disease (Covid-19), in Oceanside, California, US, April 29, 2020. REUTERS/Mike Blake/File Photo
Coronavirus chronicle

Will Gilead price its coronavirus drug for public good or company profit?